Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00321438 · ClinicalTrials.gov registry record
Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus
A clinical trial, sponsored by GlaxoSmithKline.
- Terminated
- Registry status
- 150
- Enrollment target
NCT00321438 is a clinical trial that was terminated before completion, run by GlaxoSmithKline. The registered enrollment target is 150 participants.
The verdict
NCT00321438 was terminated before completion, sponsored by GlaxoSmithKline.
- TERMINATED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to measure viral tropism over time in subjects with X4-tropic or non-phenotypeable virus while receiving standard of care therapy. This is an observational study. No investigational treatment will be administered through this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2005-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00321438
The ClinicalTrials.gov registry entry for NCT00321438 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00321438 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00321438 about?
NCT00321438 is a clinical study titled "Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus". The purpose of this study is to measure viral tropism over time in subjects with X4-tropic or non-phenotypeable virus while receiving standard of care therapy. This is an observational study. No investigational treatment will be administered through this study.
What is the current status of trial NCT00321438?
This trial is currently terminated. The enrollment target is 150 participants. The study started on 2005-07.
Who is sponsoring clinical trial NCT00321438?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.